<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    
    <title>Nano Ultrasound Contrast Agent for Synergistic Chemo-photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis | SCP Foundation Changchun Site</title>
    
    
        <meta name="keywords" content="Liver Cancer,Arsenic Trioxide (ATO),Photothermal Therapy (PTT),Ferroptosis,Immunogenic Cell Death,PD-L1 Inhibito,Ultrasound Contrast Agent,cRGD Peptide">
    
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    <meta name="description" content="Introduction Liver cancer is a major global health concern, with approximately 1 million new patients diagnosed each year. [cite: 502, 63, 64] A significant number of these patients are diagnosed a">
<meta property="og:type" content="article">
<meta property="og:title" content="Nano Ultrasound Contrast Agent for Synergistic Chemo-photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis">
<meta property="og:url" content="https://w163nana.github.io/wiki/Nano-Ultrasound-Contrast-Agent-for-Synergistic-Chemo-photothermal-Therapy-and-Enhanced-Immunotherapy-Against-Liver-Cancer-and-Metastasis/index.html">
<meta property="og:site_name" content="SCP Foundation Changchun Site">
<meta property="og:description" content="Introduction Liver cancer is a major global health concern, with approximately 1 million new patients diagnosed each year. [cite: 502, 63, 64] A significant number of these patients are diagnosed a">
<meta property="og:locale" content="en_US">
<meta property="article:published_time" content="2025-04-12T07:09:37.000Z">
<meta property="article:modified_time" content="2025-04-12T07:19:47.575Z">
<meta property="article:author" content="ChenXinqi">
<meta property="article:tag" content="Liver Cancer">
<meta property="article:tag" content="Arsenic Trioxide (ATO)">
<meta property="article:tag" content="Photothermal Therapy (PTT)">
<meta property="article:tag" content="Ferroptosis">
<meta property="article:tag" content="Immunogenic Cell Death">
<meta property="article:tag" content="PD-L1 Inhibito">
<meta property="article:tag" content="Ultrasound Contrast Agent">
<meta property="article:tag" content="cRGD Peptide">
<meta name="twitter:card" content="summary">
    

    
        <link rel="alternate" href="/atom.xml" title="SCP Foundation Changchun Site" type="application/atom+xml">
    

    
        <link rel="icon" href="/css/images/favicon.ico">
    

    
<link rel="stylesheet" href="/libs/font-awesome/css/font-awesome.min.css">

    
<link rel="stylesheet" href="/libs/open-sans/styles.css">

    
<link rel="stylesheet" href="/libs/source-code-pro/styles.css">


    
<link rel="stylesheet" href="/css/style.css">

    
<script src="/libs/jquery/2.1.3/jquery.min.js"></script>

    
<script src="/libs/jquery/plugins/cookie/1.4.1/jquery.cookie.js"></script>

    
    
        
<link rel="stylesheet" href="/libs/lightgallery/css/lightgallery.min.css">

    
    
        
<link rel="stylesheet" href="/libs/justified-gallery/justifiedGallery.min.css">

    
    
    
    


    
        <script async src="//busuanzi.ibruce.info/busuanzi/2.3/busuanzi.pure.mini.js"></script>
    
<meta name="generator" content="Hexo 7.3.0"></head>

<body>
    <div id="container">
        <header id="header">
    <div id="header-main" class="header-inner">
        <div class="outer">
            <a href="/" id="logo">
                <i class="logo"></i>
                <span class="site-title">SCP Foundation Changchun Site</span>
            </a>
            <nav id="main-nav">
                
                    <a class="main-nav-link" href="/">HOME</a>
                
                    <a class="main-nav-link" href="/archives">ARCHIVES</a>
                
                    <a class="main-nav-link" href="/categories">CATEGORIES</a>
                
                    <a class="main-nav-link" href="/tags">TAGS</a>
                
                    <a class="main-nav-link" href="/about">ABOUT</a>
                
            </nav>
            
            <div id="search-form-wrap">

    <form class="search-form">
        <input type="text" class="ins-search-input search-form-input" placeholder="Search">
        <button type="submit" class="search-form-submit"></button>
    </form>
    <div class="ins-search">
    <div class="ins-search-mask"></div>
    <div class="ins-search-container">
        <div class="ins-input-wrapper">
            <input type="text" class="ins-search-input" placeholder="Type something...">
            <span class="ins-close ins-selectable"><i class="fa fa-times-circle"></i></span>
        </div>
        <div class="ins-section-wrapper">
            <div class="ins-section-container"></div>
        </div>
    </div>
</div>
<script>
(function (window) {
    var INSIGHT_CONFIG = {
        TRANSLATION: {
            POSTS: 'Posts',
            PAGES: 'Pages',
            CATEGORIES: 'Categories',
            TAGS: 'Tags',
            UNTITLED: '(Untitled)',
        },
        ROOT_URL: '/',
        CONTENT_URL: '/content.json',
    };
    window.INSIGHT_CONFIG = INSIGHT_CONFIG;
})(window);
</script>

<script src="/js/insight.js"></script>


</div>
        </div>
    </div>
    <div id="main-nav-mobile" class="header-sub header-inner">
        <table class="menu outer">
            <tr>
                
                    <td><a class="main-nav-link" href="/">HOME</a></td>
                
                    <td><a class="main-nav-link" href="/archives">ARCHIVES</a></td>
                
                    <td><a class="main-nav-link" href="/categories">CATEGORIES</a></td>
                
                    <td><a class="main-nav-link" href="/tags">TAGS</a></td>
                
                    <td><a class="main-nav-link" href="/about">ABOUT</a></td>
                
                <td>
                    
    <div class="search-form">
        <input type="text" class="ins-search-input search-form-input" placeholder="Search">
    </div>

                </td>
            </tr>
        </table>
    </div>
</header>

        <div class="outer">
            
            
                <aside id="sidebar">
   
        
    <div class="widget-wrap" id="categories">
        <h3 class="widget-title">
            <span>categories</span>
            &nbsp;
            <a id="allExpand" href="#">
                <i class="fa fa-angle-double-down fa-2x"></i>
            </a>
        </h3>
        
        
        
         <ul class="unstyled" id="tree"> 
                    <li class="directory open">
                        <a href="#" data-role="directory">
                            <i class="fa fa-folder-open"></i>
                            &nbsp;
                            Medical Research
                        </a>
                         <ul class="unstyled" id="tree">  <li class="file active"><a href="/wiki/Nano-Ultrasound-Contrast-Agent-for-Synergistic-Chemo-photothermal-Therapy-and-Enhanced-Immunotherapy-Against-Liver-Cancer-and-Metastasis/">Nano Ultrasound Contrast Agent for Synergistic Chemo-photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis</a></li>  </ul> 
                    </li> 
                    
                    <li class="directory">
                        <a href="#" data-role="directory">
                            <i class="fa fa-folder"></i>
                            &nbsp;
                            python
                        </a>
                         <ul class="unstyled" id="tree">  <li class="file"><a href="/wiki/python%E7%88%AC%E5%8F%96YouTube%E8%A7%86%E9%A2%91%E5%A4%A7%E5%A4%B1%E8%B4%A5/">python爬取YouTube视频大失败</a></li>  </ul> 
                    </li> 
                    
                    <li class="directory">
                        <a href="#" data-role="directory">
                            <i class="fa fa-folder"></i>
                            &nbsp;
                            开发
                        </a>
                         <ul class="unstyled" id="tree">  <li class="file"><a href="/wiki/%E3%80%8A%E4%B8%9C%E5%8C%97%E8%8A%AC%E8%BE%BE%E5%93%A5%E5%A4%A7%E6%88%98%E9%82%AA%E6%81%B6%E5%85%83%E9%A6%96%E3%80%8B%E6%B8%B8%E6%88%8F%E7%AD%96%E5%88%92/">《东北芬达哥大战邪恶元首》游戏策划</a></li>  <li class="file"><a href="/wiki/%E7%AE%80%E5%8D%95%E5%AD%A6%E4%B9%A0%E5%A6%82%E4%BD%95%E5%BB%BA%E7%AB%8B%E4%BB%A3%E7%90%86%E8%A7%84%E5%88%99/">简单学习如何建立代理规则</a></li>  <li class="file"><a href="/wiki/hexo%E5%8D%9A%E5%AE%A2%E7%9A%84%E5%9B%BE%E7%89%87%E5%AD%98%E5%82%A8%E9%97%AE%E9%A2%98%E8%A7%A3%E5%86%B3/">hexo博客的图片存储问题解决</a></li>  </ul> 
                    </li> 
                    
                    <li class="directory">
                        <a href="#" data-role="directory">
                            <i class="fa fa-folder"></i>
                            &nbsp;
                            心理
                        </a>
                         <ul class="unstyled" id="tree">  <li class="file"><a href="/wiki/%E5%85%B3%E4%BA%8E%E2%80%9C%E8%BF%91%E6%97%A5%E6%9D%A5%E8%87%AA%E8%BA%AB%E5%AF%B9%E8%B4%9F%E6%80%A7%E4%BA%8B%E4%BB%B6%E7%9A%84%E6%80%9D%E7%BB%B4%E5%8F%8D%E5%88%8D%E6%84%88%E5%8F%91%E5%8A%A0%E9%87%8D%E2%80%9D%E7%9A%84%E7%8E%B0%E8%B1%A1%E8%AE%B0%E5%BD%95%E5%92%8C%E5%88%86%E6%9E%90/">关于“近日来自身对负性事件的思维反刍愈发加重”的现象记录和分析</a></li>  </ul> 
                    </li> 
                     </ul> 
    </div>
    <script>
        $(document).ready(function() {
            var iconFolderOpenClass  = 'fa-folder-open';
            var iconFolderCloseClass = 'fa-folder';
            var iconAllExpandClass = 'fa-angle-double-down';
            var iconAllPackClass = 'fa-angle-double-up';
            // Handle directory-tree expansion:
            // 左键单独展开目录
            $(document).on('click', '#categories a[data-role="directory"]', function (event) {
                event.preventDefault();

                var icon = $(this).children('.fa');
                var expanded = icon.hasClass(iconFolderOpenClass);
                var subtree = $(this).siblings('ul');
                icon.removeClass(iconFolderOpenClass).removeClass(iconFolderCloseClass);
                if (expanded) {
                    if (typeof subtree != 'undefined') {
                        subtree.slideUp({ duration: 100 });
                    }
                    icon.addClass(iconFolderCloseClass);
                } else {
                    if (typeof subtree != 'undefined') {
                        subtree.slideDown({ duration: 100 });
                    }
                    icon.addClass(iconFolderOpenClass);
                }
            });
            // 右键展开下属所有目录
            $('#categories a[data-role="directory"]').bind("contextmenu", function(event){
                event.preventDefault();
                
                var icon = $(this).children('.fa');
                var expanded = icon.hasClass(iconFolderOpenClass);
                var listNode = $(this).siblings('ul');
                var subtrees = $.merge(listNode.find('li ul'), listNode);
                var icons = $.merge(listNode.find('.fa'), icon);
                icons.removeClass(iconFolderOpenClass).removeClass(iconFolderCloseClass);
                if(expanded) {
                    subtrees.slideUp({ duration: 100 });
                    icons.addClass(iconFolderCloseClass);
                } else {
                    subtrees.slideDown({ duration: 100 });
                    icons.addClass(iconFolderOpenClass);
                }
            })
            // 展开关闭所有目录按钮
            $(document).on('click', '#allExpand', function (event) {
                event.preventDefault();
                
                var icon = $(this).children('.fa');
                var expanded = icon.hasClass(iconAllExpandClass);
                icon.removeClass(iconAllExpandClass).removeClass(iconAllPackClass);
                if(expanded) {
                    $('#sidebar .fa.fa-folder').removeClass('fa-folder').addClass('fa-folder-open')
                    $('#categories li ul').slideDown({ duration: 100 });
                    icon.addClass(iconAllPackClass);
                } else {
                    $('#sidebar .fa.fa-folder-open').removeClass('fa-folder-open').addClass('fa-folder')
                    $('#categories li ul').slideUp({ duration: 100 });
                    icon.addClass(iconAllExpandClass);
                }
            });  
        });
    </script>

    
        
    <div class="widget-wrap">
        <h3 class="widget-title"><span>tags</span></h3>
        <div class="widget">
            <ul class="tag-list" itemprop="keywords"><li class="tag-list-item"><a class="tag-list-link" href="/tags/AVG/" rel="tag">AVG</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/Arsenic-Trioxide-ATO/" rel="tag">Arsenic Trioxide (ATO)</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/Ferroptosis/" rel="tag">Ferroptosis</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/Galgame/" rel="tag">Galgame</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/Immunogenic-Cell-Death/" rel="tag">Immunogenic Cell Death</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/Liver-Cancer/" rel="tag">Liver Cancer</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/PD-L1-Inhibito/" rel="tag">PD-L1 Inhibito</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/Photothermal-Therapy-PTT/" rel="tag">Photothermal Therapy (PTT)</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/SAO/" rel="tag">SAO</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/Ultrasound-Contrast-Agent/" rel="tag">Ultrasound Contrast Agent</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/cRGD-Peptide/" rel="tag">cRGD Peptide</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/hexo/" rel="tag">hexo</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/python/" rel="tag">python</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%88%80%E5%89%91%E7%A5%9E%E5%9F%9F/" rel="tag">刀剑神域</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%8D%9A%E5%AE%A2/" rel="tag">博客</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%BC%80%E5%8F%91/" rel="tag">开发</a><span class="tag-list-count">2</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%BE%AE%E8%BD%AF/" rel="tag">微软</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E6%80%9D%E7%BB%B4%E5%8F%8D%E5%88%8D/" rel="tag">思维反刍</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E6%88%98%E6%A3%8B/" rel="tag">战棋</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E6%B8%B8%E6%88%8F/" rel="tag">游戏</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E7%88%AC%E8%99%AB/" rel="tag">爬虫</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E7%BD%91%E7%BB%9C/" rel="tag">网络</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E8%B4%9F%E6%80%A7%E4%BA%8B%E4%BB%B6/" rel="tag">负性事件</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E9%AC%BC%E7%95%9C/" rel="tag">鬼畜</a><span class="tag-list-count">1</span></li></ul>
        </div>
    </div>

    
    <div id="toTop" class="fa fa-angle-up"></div>
</aside>
            
            <section id="main"><article id="post-Nano-Ultrasound-Contrast-Agent-for-Synergistic-Chemo-photothermal-Therapy-and-Enhanced-Immunotherapy-Against-Liver-Cancer-and-Metastasis" class="article article-type-post" itemscope itemprop="blogPost">
    <div class="article-inner">
        
        
            <header class="article-header">
                
                    <div class="article-meta">
                        
    <div class="article-category">
    	<i class="fa fa-folder"></i>
        <a class="article-category-link" href="/categories/Medical-Research/">Medical Research</a>
    </div>

                        
    <div class="article-tag">
        <i class="fa fa-tag"></i>
        <a class="tag-link-link" href="/tags/Arsenic-Trioxide-ATO/" rel="tag">Arsenic Trioxide (ATO)</a>, <a class="tag-link-link" href="/tags/Ferroptosis/" rel="tag">Ferroptosis</a>, <a class="tag-link-link" href="/tags/Immunogenic-Cell-Death/" rel="tag">Immunogenic Cell Death</a>, <a class="tag-link-link" href="/tags/Liver-Cancer/" rel="tag">Liver Cancer</a>, <a class="tag-link-link" href="/tags/PD-L1-Inhibito/" rel="tag">PD-L1 Inhibito</a>, <a class="tag-link-link" href="/tags/Photothermal-Therapy-PTT/" rel="tag">Photothermal Therapy (PTT)</a>, <a class="tag-link-link" href="/tags/Ultrasound-Contrast-Agent/" rel="tag">Ultrasound Contrast Agent</a>, <a class="tag-link-link" href="/tags/cRGD-Peptide/" rel="tag">cRGD Peptide</a>
    </div>

                        
    <div class="article-date">
        <i class="fa fa-calendar"></i>
        <a href="/wiki/Nano-Ultrasound-Contrast-Agent-for-Synergistic-Chemo-photothermal-Therapy-and-Enhanced-Immunotherapy-Against-Liver-Cancer-and-Metastasis/">
            <time datetime="2025-04-12T07:09:37.000Z" itemprop="datePublished">2025-04-12</time>
        </a>
    </div>


                        
                            <i class="fa fa-bar-chart"></i>
                            <span id="busuanzi_container_site_pv"><span id="busuanzi_value_page_pv"></span></span>    
                        
                        
                    </div>
                
                
    
        <h1 class="article-title" itemprop="name">
            Nano Ultrasound Contrast Agent for Synergistic Chemo-photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis
        </h1>
    

            </header>
        
        
        <div class="article-entry" itemprop="articleBody">
        
        
            
                <div id="toc" class="toc-article">
                <strong class="toc-title">Catalogue</strong>
                    <ol class="toc"><li class="toc-item toc-level-2"><a class="toc-link" href="#introduction"><span class="toc-number">1.</span> <span class="toc-text">Introduction</span></a></li><li class="toc-item toc-level-2"><a class="toc-link" href="#detailed-discussion-of-key-components-and-mechanisms"><span class="toc-number">2.</span> <span class="toc-text">Detailed
Discussion of Key Components and Mechanisms</span></a><ol class="toc-child"><li class="toc-item toc-level-3"><a class="toc-link" href="#arsenic-trioxide-ato-and-ferroptosis"><span class="toc-number">2.1.</span> <span class="toc-text">Arsenic Trioxide (ATO) and
Ferroptosis</span></a></li><li class="toc-item toc-level-3"><a class="toc-link" href="#photothermal-therapy-ptt-and-gold-nanoparticles-aunps"><span class="toc-number">2.2.</span> <span class="toc-text">Photothermal
Therapy (PTT) and Gold Nanoparticles (AuNPs)</span></a></li><li class="toc-item toc-level-3"><a class="toc-link" href="#ultrasound-targeted-microbubble-destruction-utmd"><span class="toc-number">2.3.</span> <span class="toc-text">Ultrasound-Targeted
Microbubble Destruction (UTMD)</span></a></li><li class="toc-item toc-level-3"><a class="toc-link" href="#the-role-of-crgd-peptide"><span class="toc-number">2.4.</span> <span class="toc-text">The Role of cRGD Peptide</span></a></li><li class="toc-item toc-level-3"><a class="toc-link" href="#perfluorohexane-pfh-and-ultrasound-imaging"><span class="toc-number">2.5.</span> <span class="toc-text">Perfluorohexane
(PFH) and Ultrasound Imaging</span></a></li></ol></li><li class="toc-item toc-level-2"><a class="toc-link" href="#mechanism-of-action-of-the-nano-agent"><span class="toc-number">3.</span> <span class="toc-text">Mechanism of Action of
the Nano-Agent</span></a></li><li class="toc-item toc-level-2"><a class="toc-link" href="#synthesis-and-characterization-of-the-nano-agent"><span class="toc-number">4.</span> <span class="toc-text">Synthesis and
Characterization of the Nano-Agent</span></a></li><li class="toc-item toc-level-2"><a class="toc-link" href="#in-vitro-drug-release-and-ultrasound-imaging"><span class="toc-number">5.</span> <span class="toc-text">In Vitro Drug
Release and Ultrasound Imaging</span></a></li><li class="toc-item toc-level-2"><a class="toc-link" href="#references"><span class="toc-number">6.</span> <span class="toc-text">References</span></a></li></ol>
                </div>
            
        
        
            <h2 id="introduction">Introduction</h2>
<p>Liver cancer is a major global health concern, with approximately 1
million new patients diagnosed each year. [cite: 502, 63, 64] A
significant number of these patients are diagnosed at an advanced stage,
making them ineligible for surgical treatments. [cite: 502, 63, 64] In
such cases, traditional treatment methods like thermal ablation,
chemotherapy, and immunotherapy often yield unsatisfactory results due
to the complexity and heterogeneity of the tumor. [cite: 503, 65] The
propensity of liver cancer to metastasize adds another layer of
difficulty to treatment and severely impacts patient prognosis. [cite:
504, 66] Consequently, there’s a critical need for research focused on
developing effective combination therapies that can enhance treatment
efficacy and reduce metastasis. [cite: 505, 67]</p>
<p>Combination therapy, which strategically employs multiple treatment
modalities, has emerged as a promising approach to improve outcomes.
[cite: 493, 54] By targeting various pathways and modulating the tumor’s
immune microenvironment, combination therapy can more effectively
disrupt cancer progression. [cite: 493, 54] Among the innovative tools
being explored for liver cancer treatment, nanodrug delivery systems
hold significant promise. [cite: 494, 55] These systems offer the
potential for targeted drug delivery, reduced toxicity, and enhanced
therapeutic efficacy. [cite: 494, 55]</p>
<p>This study introduces a novel nano ultrasound contrast agent,
abbreviated as ATO/PFH NPs@Au-cRGD, designed to integrate diagnosis and
treatment for efficient ultrasound imaging and liver cancer therapy.
[cite: 495, 56]</p>
<p>The core components of this system are:</p>
<ul>
<li><p><strong>Arsenic trioxide (ATO):</strong> A therapeutic agent
known to induce ferroptosis, a distinct form of programmed cell death,
in tumor cells. [cite: 495, 56, 512, 74]</p></li>
<li><p><strong>Perfluorohexane (PFH):</strong> A substance used to
enhance the ultrasound echo signal. [cite: 495, 56, 528, 94]</p></li>
<li><p><strong>Gold nanoparticles (AuNPs):</strong> Act as a carrier for
ATO and PFH and facilitate photothermal therapy (PTT). [cite: 495, 56,
508, 70]</p></li>
<li><p><strong>cRGD peptide:</strong> A targeting ligand that enhances
the delivery of the nano-agent to liver cancer cells. [cite: 495, 56,
529, 95]</p></li>
</ul>
<p>The research demonstrates that this nanodrug delivery system promotes
the release of tumor-associated antigens (TAAs) through ATO-induced
ferroptosis and photothermal-induced immunogenic cell death. [cite: 496,
57] This process enhances the synergistic effects of ATO and
photothermal therapy in human Huh7 and mouse Hepa1-6 cells. [cite: 496,
57]</p>
<p>A key finding of the study is the system’s ability to activate the
antitumor immune response and promote macrophage M1 polarization within
the tumor microenvironment. [cite: 497, 58] Notably, these beneficial
effects were observed with low side effects in both subcutaneous and
orthotopic liver cancer models. [cite: 497, 58]</p>
<p>Furthermore, the research reveals that combining the nanodrug
delivery system with anti-programmed death-ligand 1 (PD-L1)
immunotherapy inhibits tumor metastasis and establishes long-term
immunological memory in orthotopic liver cancer. [cite: 498, 59] This
combination not only enhances antitumor therapy and suppresses lung
metastasis but also enables visual assessment of therapeutic efficacy.
[cite: 499, 60] These capabilities highlight the significant potential
of this nano-agent for clinical applications in treating liver cancer.
[cite: 499, 60]</p>
<h2 id="detailed-discussion-of-key-components-and-mechanisms">Detailed
Discussion of Key Components and Mechanisms</h2>
<h3 id="arsenic-trioxide-ato-and-ferroptosis">Arsenic Trioxide (ATO) and
Ferroptosis</h3>
<p>Arsenic trioxide (ATO) has shown considerable clinical benefits in
the palliative treatment of unresectable primary liver cancer. [cite:
518, 83] However, its clinical application is limited by high systemic
toxicity, rapid renal elimination of ATO, and low delivery efficiency to
liver cancer cells, which greatly reduce the therapeutic efficacy and
lead to severe systemic toxicity. [cite: 519, 84, 520, 85, 86]</p>
<p>To address these limitations, nanotechnology-based nanodrug delivery
systems offer a promising solution. [cite: 521, 87] These systems can
significantly improve the efficacy of ATO, reduce its toxicity, and
achieve targeted drug delivery in liver cancer. [cite: 521, 87] Since
ATO has a strong affinity for sulfhydryl groups (SH) in proteins, it can
theoretically inactivate a variety of enzymes containing SH, such as
glutathione (GSH). [cite: 521, 87]</p>
<p>Glutathione (GSH) could assist glutathione peroxidase 4 (GPX4) in
reducing toxic lipid peroxides (LPOs) to nontoxic hydroxy compound (LOH)
to prevent LPO-mediated damage to cell membrane structure and function.
[cite: 522, 88] The depletion of GSH could result in the inhibition of
GPX4 activity and a corresponding increase in intracellular LPO levels,
ultimately leading to ferroptosis. [cite: 522, 88] Therefore, ATO may
induce ferroptosis through GSH depletion and GPX4 inactivation. [cite:
522, 88] Moreover, the ferroptosis-induced release of TAAs from dying
cancer cells could further enhance the immune response. [cite: 522,
88]</p>
<h3 id="photothermal-therapy-ptt-and-gold-nanoparticles-aunps">Photothermal
Therapy (PTT) and Gold Nanoparticles (AuNPs)</h3>
<p>Photothermal therapy (PTT) is an anticancer strategy that offers
precise targeting of tumors with minimal damage to surrounding healthy
tissues. [cite: 506, 68, 507, 69] Gold nanoparticles (AuNPs) are
well-suited for PTT applications due to their good biocompatibility and
excellent optical properties. [cite: 508, 70]</p>
<p>When AuNPs are exposed to near-infrared (NIR) light, they efficiently
absorb the light energy and convert it into heat. [cite: 509, 71] This
photothermal effect can damage tumor tissues or release therapeutic
molecules, such as tumor-associated antigens (TAAs). [cite: 509, 71,
516, 80] However, the therapeutic effect of AuNPs alone may be limited.
[cite: 516, 80, 517, 81] The synergistic effect of combined chemo-PTT
may be a promising strategy for improving PTT efficacy. [cite: 517, 81,
506, 68]</p>
<h3 id="ultrasound-targeted-microbubble-destruction-utmd">Ultrasound-Targeted
Microbubble Destruction (UTMD)</h3>
<p>Ultrasound-targeted microbubble destruction (UTMD) can be exploited
to change the structures of cells to facilitate the targeted release of
nanodrugs into tumor cells, which could improve the efficacy of tumor
treatment and prevent the systemic toxicity of antitumor drugs. [cite:
525, 91] The nanoparticles (NPs) accumulate in tumor tissues through the
enhanced permeability and retention effect (EPR) and targeting effect.
[cite: 526, 92] Then, UTMD can increase the permeability of the cell
membrane through the cavitation effect so that the drugs loaded in NPs
are more easily released and taken up. [cite: 527, 93] Moreover, NPs can
also load imaging agents for visualizing therapy, such as
perfluorohexane (PFH). [cite: 528, 94]</p>
<h3 id="the-role-of-crgd-peptide">The Role of cRGD Peptide</h3>
<p>In this study, the nanodrug delivery system is conjugated with the
cyclic arginylglycylaspartic acid peptide (cRGD). [cite: 529, 95, 530,
96] Since ανβ3 integrin-specific ligands are overexpressed in liver
cancer and neovascularization cells, a cyclic arginylglycylaspartic acid
peptide (cRGD) can be bound to AuNPs via gold-sulfur bonds for targeted
liver cancer therapy. [cite: 530, 96, 531, 97, 532, 98]</p>
<h3 id="perfluorohexane-pfh-and-ultrasound-imaging">Perfluorohexane
(PFH) and Ultrasound Imaging</h3>
<p>Perfluorohexane (PFH) is a stable, safe, and nontoxic liquid that can
undergo a phase transition and enhance the ultrasound echo signal under
ultrasonic stimulation and photothermal effects. [cite: 528, 94, 529,
95, 535, 100] This property makes it valuable for ultrasound imaging,
allowing for the visualization of the nano-agent’s distribution and
therapeutic effects. [cite: 535, 100, 536, 101]</p>
<h2 id="mechanism-of-action-of-the-nano-agent">Mechanism of Action of
the Nano-Agent</h2>
<p>The nano ultrasound contrast agent, ATO/PFH NPs@Au-cRGD, functions
through a multifaceted mechanism:</p>
<ol type="1">
<li><p><strong>Induction of Ferroptosis:</strong> ATO induces
ferroptosis in tumor cells through GSH depletion and increased GPX4.
[cite: 512, 74] The increased ROS can also directly kill tumor cells,
thereby enhancing the synergistic effect. [cite: 512, 74, 513, 75, 513,
76, 514, 77]</p></li>
<li><p><strong>Photothermal Effect:</strong> AuNPs generate heat under
NIR laser irradiation, contributing to tumor cell death. [cite: 506, 68,
507, 69, 508, 70, 509, 71]</p></li>
<li><p><strong>Immune Modulation:</strong> Ferroptosis and photothermal
effects promote the maturation of dendritic cells (DCs) and macrophage
M1 polarization in the tumor microenvironment (TME). [cite: 514, 78]
This activation of the immune system triggers an adaptive T-cell
response, leading to the generation of cytotoxic T lymphocytes that can
attack tumor cells. [cite: 514, 78]</p></li>
<li><p><strong>Enhanced Immunotherapy:</strong> The anti-PD-L1 mAb
further promotes the anti-tumor effect of cytotoxic T lymphocytes by
blocking the PD-1/PD-L1 axis, which enables synergistic treatment of
orthotopic liver cancer, enhances the immune response, and reduces lung
metastasis. [cite: 515, 79]</p></li>
</ol>
<p>In essence, this nanodrug delivery system could realize visual
imaging, enable synergistic treatment of liver cancer, enhance the
immune response and influence the phenotypes of macrophages in TME,
thereby achieving enhanced liver tumor therapy, reducing metastasis, and
enabling visual assessment of therapeutic efficacy. [cite: 536, 101,
537, 102]</p>
<h2 id="synthesis-and-characterization-of-the-nano-agent">Synthesis and
Characterization of the Nano-Agent</h2>
<p>The ATO/PFH NPs@Au-cRGD nano-agent is synthesized using a
filming-rehydration method with minor modifications to established
protocols. [cite: 538, 103, 539, 104]</p>
<ul>
<li><p><strong>Lipid Membranes:</strong> <span class="math-inline">DSPE-PEG_{2K}</span> , a biocompatible,
biodegradable, and amphiphilic material, is used as a backbone to
construct aptamer-functionalized core-shell nanoparticles. [cite: 539,
104, 540, 105, 541, 106] <span class="math-inline">DSPE-PEG_{2k}</span>-SI, DOTAP, DPPC, and
cholesterol formed lipid membranes to load ATO and PFH, and to
synthesize ATO/PFH NPs. [cite: 541, 106, 542, 107]</p></li>
<li><p><strong>Gold Nanoshells:</strong> AuNPs were deposited onto the
surface of liposomes via reduction of chloroauric acid <span class="math-inline">(HAuCl_{4})</span> following a previously reported
method. [cite: 542, 107, 533, 98, 534, 99, 543, 108] Then, RGD-SH binds
to the gold shell through SH bonds. [cite: 542, 107, 533, 98, 534, 99,
543, 108]</p></li>
<li><p><strong>cRGD Conjugation:</strong> cRGD-SH is then bound to the
gold shell via SH bonds to achieve targeted delivery. [cite: 542, 107,
533, 98, 534, 99, 543, 108]</p></li>
</ul>
<p>The successful synthesis of the nano-agent is confirmed through
various characterization techniques:</p>
<ul>
<li><p><strong>Transmission Electron Microscopy (TEM):</strong> TEM
confirmed the deposition of AuNPs on the liposome surface. [cite: 543,
108, 544, 109]</p></li>
<li><p><strong>Hydrodynamic Diameter and Zeta Potential:</strong> The
hydrodynamic diameter was 121 ± 5 nm, and the Zeta potential was 10.47 ±
1.20 mV in aqueous solution. [cite: 544, 109, 545, 110, 546,
111]</p></li>
<li><p><strong>Size Distribution:</strong> The size range of the ATO/PFH
NPs@Au-cRGD was ≈100-150 nm. [cite: 545, 110, 546, 111]</p></li>
<li><p><strong>Stability Analysis:</strong> After storage at 4, 25, and
37°C in phosphate-buffered saline (PBS) and serum (5%, pH 7.4) for 7
days, there was no obvious change in particle size and Zeta potential,
indicating good stability of the synthesized nanoparticles. [cite: 546,
111, 547, 112]</p></li>
<li><p><strong>UV-Vis Spectra:</strong> UV-vis spectra showed that
ATO/PFH NPs@Au-cRGD had a characteristic plasmonic coupling (between the
AuNPs) absorption peak at 760 nm, while no resonance peak at the
near-infrared wavelengths was detected in non-coated liposomes. [cite:
547, 112, 548, 113, 549, 114]</p></li>
<li><p><strong>Energy-Dispersive X-ray Spectroscopy (EDS):</strong> EDS
analysis further confirms the formation of a gold shell surrounding the
liposome core. [cite: 547, 112, 548, 113, 549, 114]</p></li>
</ul>
<h2 id="in-vitro-drug-release-and-ultrasound-imaging">In Vitro Drug
Release and Ultrasound Imaging</h2>
<p>The study also investigates the controlled release ability of ATO
from the nanodrug delivery system and its ultrasound imaging
capabilities. [cite: 549, 115, 550, 116]</p>
<ul>
<li><p><strong>Drug Release:</strong> The drug release characteristics
of ATO were detected at pH 7.4 and 6.5 (pH 6.5 was used to simulate the
slightly acidic TME). [cite: 549, 115, 550, 116, 551, 117, 552, 118]
Compared to the fast release of free ATO (≈92% in 24 h), ATO NPs-cRGD
showed significant sustained release. [cite: 551, 117, 552, 118] ATO can
be effectively released with the aid of an ultrasound therapeutic
apparatus and low acidity TME (PH 6.5). [cite: 553, 120, 554, 121] The
acoustic cavitation effect generated by UTMD is a process of vibration,
expansion, contraction, and rupture of microbubbles, which lead to the
destruction of the nanocarrier and the release of the drug encapsulated
in the nanoparticles, thus promoting the selective release at the tumor
site. [cite: 555, 122]</p></li>
<li><p><strong>Ultrasound Imaging:</strong> In vivo and in vitro imaging
experiments were carried out with saline as a negative control and
SonoVue contrast agent as a positive control to evaluate the ultrasound
imaging ability of ATO/PFH NPs@Au-cRGD. [cite: 556, 123, 557, 124, 558,
125] The contrast-enhanced images of SonoVue and ATO/PFH NPs@Au-CRGD
were significantly enhanced in vitro after ultrasound exposure, and
similar results were detected in in vivo imaging. [cite: 556, 123, 557,
124, 558, 125] Compared to commercial ultrasound contrast agents, the
ATO/PFH NPS@Au-cRGD exhibited similar ultrasound imaging effects in
tumors, clearly showing contrast enhancement in contrast mode, which
could assess the dynamic blood perfusion of tumors visually, thereby
realizing precise molecular imaging during treatment. [cite: 560,
127]</p></li>
<li><p><strong>Photothermal Properties:</strong> The photothermal
properties of the ATO/PFH NPs@Au-cRGD were investigated using a 760 nm
laser to irradiate PBS, AuNPs, ATO, and ATO NPs@Au-cRGD. [cite: 561,
128, 562, 129] After 4 min of irradiation, the maximum temperatures of
the AuNPs and ATO NPs@Au-cRGD were 54.2 ± 0.6°C and 48.7 ± 0.7°C,
respectively.</p></li>
</ul>
<h2 id="references">References</h2>
<blockquote>
<ul>
<li><a target="_blank" rel="external nofollow noopener noreferrer" href="https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202300878">Qiu
Y, Wu Z, Chen Y, Liao J, Zhang Q, Wang Q, Duan Y, Gong K, Chen S, Wang
L, Fan P, Duan Y, Wang W, Dong Y. Nano Ultrasound Contrast Agent for
Synergistic Chemo-photothermal Therapy and Enhanced Immunotherapy
Against Liver Cancer and Metastasis. Adv Sci (Weinh). 2023
Jul;10(21):e2300878. doi: 10.1002/advs.202300878. Epub 2023 May 10.
PMID: 37162268; PMCID: PMC10375134.</a></li>
</ul>
</blockquote>

            </div>
        
        <footer class="article-footer">
        </footer>
    </div>
</article>


    
<nav id="article-nav">
    
        <a href="/wiki/%E3%80%8A%E4%B8%9C%E5%8C%97%E8%8A%AC%E8%BE%BE%E5%93%A5%E5%A4%A7%E6%88%98%E9%82%AA%E6%81%B6%E5%85%83%E9%A6%96%E3%80%8B%E6%B8%B8%E6%88%8F%E7%AD%96%E5%88%92/" id="article-nav-newer" class="article-nav-link-wrap">
            <strong class="article-nav-caption">Newer</strong>
            <div class="article-nav-title">
                
                    《东北芬达哥大战邪恶元首》游戏策划
                
            </div>
        </a>
    
    
</nav>





    
    




<!-- baidu url auto push script -->
<script type="text/javascript">
    !function(){var e=/([http|https]:\/\/[a-zA-Z0-9\_\.]+\.baidu\.com)/gi,r=window.location.href,o=document.referrer;if(!e.test(r)){var n="//api.share.baidu.com/s.gif";o?(n+="?r="+encodeURIComponent(document.referrer),r&&(n+="&l="+r)):r&&(n+="?l="+r);var t=new Image;t.src=n}}(window);
</script>     
</section>
        </div>
        <footer id="footer">
    <div class="outer">
        <div id="footer-info" class="inner">
            ChenXinqi &copy; 2025 
            <a rel="external nofollow noopener noreferrer" target="_blank" href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><img alt="Creative Commons License" style="border-width:0" src="https://i.creativecommons.org/l/by-nc-nd/4.0/80x15.png"></a>
            <br> Powered by <a href="http://hexo.io/" target="_blank" rel="external nofollow noopener noreferrer">Hexo</a>. Theme - <a target="_blank" rel="external nofollow noopener noreferrer" href="https://github.com/zthxxx/hexo-theme-Wikitten">wikitten</a>
            
                <br>
                <span id="busuanzi_container_site_pv"><i class="fa fa-eye"></i> <span id="busuanzi_value_site_pv"></span></span>
                &nbsp;|&nbsp;
                <span id="busuanzi_container_site_pv"><i class="fa fa-user"></i> <span id="busuanzi_value_site_uv"></span></span>
            
        </div>
    </div>
</footer>

        

    
        
<script src="/libs/lightgallery/js/lightgallery.min.js"></script>

        
<script src="/libs/lightgallery/js/lg-thumbnail.min.js"></script>

        
<script src="/libs/lightgallery/js/lg-pager.min.js"></script>

        
<script src="/libs/lightgallery/js/lg-autoplay.min.js"></script>

        
<script src="/libs/lightgallery/js/lg-fullscreen.min.js"></script>

        
<script src="/libs/lightgallery/js/lg-zoom.min.js"></script>

        
<script src="/libs/lightgallery/js/lg-hash.min.js"></script>

        
<script src="/libs/lightgallery/js/lg-share.min.js"></script>

        
<script src="/libs/lightgallery/js/lg-video.min.js"></script>

    
    
        
<script src="/libs/justified-gallery/jquery.justifiedGallery.min.js"></script>

    
    
        <script type="text/x-mathjax-config">
    MathJax.Hub.Config({
        tex2jax: {
            inlineMath: [ ["$","$"], ["\\(","\\)"] ],
            skipTags: ['script', 'noscript', 'style', 'textarea', 'pre', 'code'],
            processEscapes: true,
            TeX: {
                equationNumbers: {
                  autoNumber: 'AMS'
                }
            }
        }
    });
    MathJax.Hub.Queue(function() {
        var all = MathJax.Hub.getAllJax();
        for (var i = 0; i < all.length; ++i)
            all[i].SourceElement().parentNode.className += ' has-jax';
    });
</script>
<script async src="//cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
    



<!-- Custom Scripts -->

<script src="/js/main.js"></script>


    </div>
</body>
</html>